Research
June 24, 2021
UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer
LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…
June 14, 2021
UAMS Project Part of National Effort to Reduce COVID-19 in Hardest Hit Populations
LITTLE ROCK — UAMS researchers and their community partners across Arkansas are studying the causes behind COVID-19’s devastating impact on minorities and developing plans to help increase vaccination rates.
June 4, 2021
Arkansas College Students Learn About COVID-19, Other Infectious Diseases at UAMS-led Workshop
UAMS treated Arkansas college students interested in research or medical careers involving infectious diseases like COVID-19 to a workshop May 19.
June 3, 2021
UAMS Donald W. Reynolds Institute on Aging Receives $1.9 Million Grant to Research Link Between Blood Sugar, Alzheimer’s Disease
The Donald W. Reynolds Institute on Aging at the University of Arkansas for Medical Sciences (UAMS) has been awarded a five-year, $1.9 million grant from the National Institute on Aging, a division of the National Institutes of Health.
May 11, 2021
UAMS Cancer Researcher Hong-yu Li, Ph.D., Awarded $1.27 Million Grant
LITTLE ROCK — Hong-yu Li, Ph.D., a researcher with the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), recently received a five-year, $1,265,834 grant from the National Institutes of Health and the National Cancer Institute to work toward developing treatment options for acute myeloid leukemia patients. Li, a professor…
May 10, 2021
NIH Grant Supporting UAMS Study of Drugs to Improve Long-term Kidney Transplant Outcomes
LITTLE ROCK — A National Institutes of Health (NIH) grant will allow UAMS researcher Nirmala Parajuli, DVM, Ph.D., to study a novel way to improve the long-term outcomes of patients who receive kidneys from deceased donors. Parajuli, an assistant professor in the College of Medicine Department of Pharmacology and Toxicology, will use the five-year $2.46…
May 7, 2021
UAMS Physician’s New Skills and Lucky Timing Save Vilonia Baby from Deadly, Disabling Disease
Oliver Hurst owes his life to a luckily timed move across the country. His father and mother, who was then three months pregnant with Oliver, arrived in Vilonia from California in March 2020. At the time, UAMS’ Kapil Arya, M.D., was developing strategies as a UAMS Translational Research Institute Implementation Science Scholar to establish statewide…
May 5, 2021
Latest Virtual Showcase of Medical Discoveries Focuses on Cardiovascular Research
Efforts to better understand heart problems and improve methods of detection and outcomes were the focus of the University of Arkansas for Medical Sciences (UAMS) most recent Showcase of Medical Discoveries, this time focused on cardiovascular research. The virtual event, held April 21, was the 30th showcase sponsored by the UAMS Division of Research and…
May 3, 2021
American Heart Association’s Sweethearts Learn About Heart From UAMS Experts
About 35 high school sophomores who are part of the American Heart Association’s Sweetheart Program got a close look into the inner workings of the heart in a virtual session April 26 at the University of Arkansas for Medical Sciences (UAMS). The Sweethearts are high school sophomores who, over several months, learn about heart-healthy lifestyles…
April 26, 2021
UAMS Studies Highlight Endocrine Disorders that Put Children at Higher Risk for COVID-19 Complications, Death
COVID-19 infections put children at much higher risk for complications and death if they have either poorly controlled diabetes or adrenal insufficiency, according to two studies by researchers at the University of Arkansas for Medical Sciences (UAMS). One study found that children with poorly controlled Type 1 diabetes have a much higher risk of COVID-19-related…
Previous page Next page